Second Annual Clinical Advances in the Diagnosis and Management of Pulmonary Hypertension

undefined

Join us January 27, 2018 in La Jolla!

Join us January 27, 2018 in La Jolla!

This CME conference is designed to educate clinicians on state-of-the-art care for pulmonary hypertension.

About the Conference

About the Conference

Conference Location

Conference Location

The Schaetzel Center

Scripps Memorial Hospital

9890 Genesee Ave

La Jolla, California 92037

Conference Details

Conference Details

Course Overview

Course Overview

Pulmonary hypertension (PH) is a common and widely misunderstood syndrome that results from a surprisingly large number of disease processes. It can occur at any age and the risk of developing PH increases with age and other medical conditions. Great strides have been made in the past 15 years in diagnosing and treating pulmonary arterial hypertension (PAH) so that the natural history of PAH is rapidly changing. On the other hand, the more common clinical variant, pulmonary venous hypertension (PVH) has been largely unaffected by medical therapy. In addition, there is often a divide between those whose treat PAH and those clinicians whose patients have PVH and are frustrated by the lack of effective therapy.


This conference will be unique in that it will cover all forms of pulmonary hypertension. Expert faculty will discuss the epidemiology of PH, how PH is diagnosed, and the poor outcomes associated with PH when left untreated. Clinicians will leave with a better understanding of the difference between PAH and PVH and why the difference matters. Therapies for PAH and PVH will also be discussed with reference to current clinical guidelines. Participants will return to their practice equipped with the latest evidence base and practical information to improve patient outcomes.

Educational Objectives

Educational Objectives

After attending this live activity, participants should be able to:

  • Describe the epidemiology and pathophysiology of pulmonary hypertension.
  • Determine who is at risk for pulmonary hypertension and effectively diagnose patients.
  • Recognize the difference between PAH and PVH and how this translates into therapy.
  • Outline the current approach to pulmonary hypertension treatment in the presence of related or underlying diseases.
  • Evaluate current pharmacologic and medical management strategies for patients with pulmonary hypertension.
  • Incorporate novel therapies into patient care for improved outcomes.
  • Identify when to refer patients for specialty treatment.

Accreditation and Disclosures

Accreditation and Disclosures

Physicians

Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


Commercial Support

This course is supported, in part, by educational grants from industry, in accordance with ACCME accreditation Standards for Commercial Support. Appropriate acknowledgement will be given to all supporters at the time of the educational activity.


Cultural and Linguistic Competency

This activity is in compliance with California Assembly Bill 1195, which requires that all CME activities comprising a patient care element include curriculum addressing the topic of cultural and linguistic competency. The intent of this bill is to ensure that health care professionals are able to meet the cultural and linguistic concerns of a diverse patient population through effective and appropriate professional development. The planners, speakers and authors of this CME activity have been encouraged to address issues relevant in their topic area. A variety of resources are available that address cultural and linguistic competency, some of which can be found in the Cultural & Linguistic Competency Resource Guide.

Event Details
Date Time
Sat, Jan 27th, 2018 - Sat, Jan 27th, 2018 7:30 AM - 1:00 PM